The pharmacokinetics of aspirin (ASA) in acute migraine attacks, and the influence of metoclopramide on ASA disposition, were studied in 32 attacks in 30 patients. An intergroup comparison was made between normal volunteers, and the migraineurs, who were assigned at random to one of three treatment groups: a) oral ASA only (900 mg); b) 10 mg oral metoclopramide + oral ASA 900 mg; c) 10 mg i. m. metoclopramide + oral ASA 900 mg. Plasma ASA and SA levels were measured serially over 2 h, and the resultant data evaluated pharmacokinetically. Metoclopramide plasma levels were also determined over 2 h, and the results compared with a second group of normal volunteers. The rates of oral ASA absorption and elimination were unaffected by migraine. M...
Introduction: Drugs used in the treatment of migraine have been reported to be highly associated wit...
Claims that twice-daily dosage of choline magnesium trisalicylate (CMT) may alter salicylate disposa...
This study was a multinational, multicentre, double-blind, active controlled phase III trial designe...
Introduction: For more than a century, aspirin has been used for the acute treatment of primary head...
This study examined the pharmacokinetics of 300 mg of tiaprofenic acid, a NSAID belonging to the 2-a...
A retrospective study of the efficacy of soluble aspirin in migraine has been carried out. Data were...
Salivary salicylate concentrations were used to study the pharmacokinetics of a sustained release as...
Naproxen is an anti-inflammatory drug widely used in the management of pain and in the treatment of ...
Introduction: Recommended medications for the acute treatment of migraine encompass triptans, nonste...
Aspirin has been used therapeutically for over 100 years. As the originator and an important market...
Recent progress in the treatment of primary headaches has made available specific, effective and saf...
Naproxen is an anti-inflammatory drug widely used in the management of pain and in the treatment of ...
This preliminary study examined the pharmacokinetics of 300 mg of tiaprofenic acid, in single oral d...
Aspirin is commonly used to treat migraine attacks, although sumatriptan, a much more expensive trea...
Sumatriptan was the first selective serotonin (5-HT) 1B/1D agonist for the acute treatment of migrai...
Introduction: Drugs used in the treatment of migraine have been reported to be highly associated wit...
Claims that twice-daily dosage of choline magnesium trisalicylate (CMT) may alter salicylate disposa...
This study was a multinational, multicentre, double-blind, active controlled phase III trial designe...
Introduction: For more than a century, aspirin has been used for the acute treatment of primary head...
This study examined the pharmacokinetics of 300 mg of tiaprofenic acid, a NSAID belonging to the 2-a...
A retrospective study of the efficacy of soluble aspirin in migraine has been carried out. Data were...
Salivary salicylate concentrations were used to study the pharmacokinetics of a sustained release as...
Naproxen is an anti-inflammatory drug widely used in the management of pain and in the treatment of ...
Introduction: Recommended medications for the acute treatment of migraine encompass triptans, nonste...
Aspirin has been used therapeutically for over 100 years. As the originator and an important market...
Recent progress in the treatment of primary headaches has made available specific, effective and saf...
Naproxen is an anti-inflammatory drug widely used in the management of pain and in the treatment of ...
This preliminary study examined the pharmacokinetics of 300 mg of tiaprofenic acid, in single oral d...
Aspirin is commonly used to treat migraine attacks, although sumatriptan, a much more expensive trea...
Sumatriptan was the first selective serotonin (5-HT) 1B/1D agonist for the acute treatment of migrai...
Introduction: Drugs used in the treatment of migraine have been reported to be highly associated wit...
Claims that twice-daily dosage of choline magnesium trisalicylate (CMT) may alter salicylate disposa...
This study was a multinational, multicentre, double-blind, active controlled phase III trial designe...